SIK1 Polyclonal Antibody

Catalytic activity:ATP + a protein = ADP + a phosphoprotein.,cofactor:Magnesium.,enzyme regulation:Activated by phosphorylation on Thr-182 by STK11 in complex with STE20-related adapter-alpha (STRAD alpha) pseudo kinase and CAB39.,Transient role during the earliest stages of myocardial cell differentiation and/or primitive chamber formation and may also be important for the earliest stages of skeletal muscle growth and/or differentiation. Potential role in G2/M cell cycle regulation. Inhibits CREB activity by phosphorylating and repressing the CREB-specific coactivators, CRTC1-3.,PTM:Phosphorylated upon DNA damage, probably by ATM or ATR.,Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. AMPK subfamily.,Contains 1 protein kinase domain.,Contains 1 UBA domain.,subcellular location:Translocates to the cytoplasm on phosphorylation where it binds binding to YWHAZ.,subunit:Binds to and is activated by YWHAZ when phosphorylated on Thr-182.,

Introducing the Sik1 Polyclonal Antibody, meticulously developed by the esteemed BT Lab in collaboration with Dana Biosciences. This cutting-edge product is designed to revolutionize the field of molecular biology, offering researchers an invaluable tool for their scientific endeavors.

Crafted with utmost precision and expertise, the Sik1 Polyclonal Antibody exhibits exceptional specificity and sensitivity, ensuring accurate and reliable results in a wide range of applications. This antibody is meticulously purified, guaranteeing the highest level of purity and minimizing any potential cross-reactivity.

The Sik1 Polyclonal Antibody boasts an impressive affinity for its target protein, Sik1, a key regulator in various cellular processes. Its exceptional binding capacity enables researchers to explore the intricate mechanisms underlying Sik1's function, paving the way for groundbreaking discoveries and advancements in the field.

With its robust performance, the Sik1 Polyclonal Antibody is an indispensable asset in numerous experimental techniques, including Western blotting, immunohistochemistry, and immunofluorescence. Its versatility allows for seamless integration into diverse research projects, facilitating comprehensive investigations into Sik1's role in cellular signaling pathways and disease progression.

Furthermore, the Sik1 Polyclonal Antibody is meticulously validated through rigorous quality control measures, ensuring consistent and reproducible results. Its exceptional stability and long shelf life guarantee optimal performance, making it an ideal choice for both short-term and long-term studies.

In summary, the Sik1 Polyclonal Antibody by BT Lab, in collaboration with Dana Biosciences, represents a pinnacle of scientific innovation. With its unparalleled specificity, sensitivity, and versatility, this antibody empowers researchers to unravel the complexities of Sik1's function, ultimately driving advancements in molecular biology and paving the way for a brighter scientific future.